Gufic Biosciences board approves amalgamation with Gufic Lifesciences
New Delhi: Gufic Bioscience has recently announced that board has approved the scheme of amalgamation of Gufic Lifesciences with the company, in a move aimed at providing larger asset base to boost growth and development of its business.
Gufic Biosciences Limited is primarily engaged in the business of manufacture, job work, marketing and sale of formulations and bulk drugs. Its turnover stood at Rs 304.12 crore as on March 31, 2018.
Gufic Lifesciences is one of the largest manufacturers of Lyophilized injections in India.
"The amalgamation would help achieve synergies of operations and streamline business activities," Gufic Biosciences said in a regulatory filing.
Read Also: Gufic Biosciences to merge Gufic Stridden Bio-Pharma with self
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd